Niva Bupa Health Insurance Company Limited announced that a Board of Directors meeting will be held on January 29, 2026. The agenda includes the review and approval of the unaudited financial results for the quarter and nine months ended December 31, 2025. The board will also review the unaudited interim condensed IFRS financial statements for the same period. The trading window will remain closed until January 31, 2026.
Board Meeting Announcement
Niva Bupa Health Insurance Company Limited has scheduled a meeting of its Board of Directors for January 29, 2026. Key items on the agenda pertain to the company’s financial performance.
Financial Results Review
The primary focus of the meeting will be to consider and approve the unaudited financial results for the quarter and nine months which ended on December 31, 2025. This review will give stakeholders insight into the company’s performance during that period. In addition, the Board will consider and approve the unaudited interim condensed IFRS financial statements covering the same nine-month duration, ensuring adherence to international reporting standards.
Trading Window Closure
In line with standard procedure ahead of financial results announcements, Niva Bupa has confirmed that the trading window will remain closed until January 31, 2026. This measure ensures compliance and prevents any potential insider trading activities, maintaining fairness and transparency for all investors. This is in continuation of the company’s letter dated December 30, 2025 regarding trading window closure.
Source: BSE
